@josephinvesting
22 y/o in management consulting. Stocks, research & opinions. Retail investor, positions will change. Never financial advice, DYOR
Science
Nautilus Biotechnology says its Voyager platform would quantify tau and EWS::FLI1 proteoforms in the planned SEEDS research.
